not been proven, A. platys is believed to be transmitted by Rhipicephalus sanguineus, a tick found worldwide, which transmits Ehrlichia canis, Babesia spp., and other pathogens. In the United States, canine cyclic thrombocytopenia is more commonly reported in the south. In northeastern Arizona, a region in which only R. sanguineus is found, 10.2-12.4% of dogs were seroreactive to Anaplasma spp. 6 In North America, A. platys is considered less pathogenic than A. phagocytophilum; however, reported clinical abnormalities include fever, anorexia, bleeding disorders, and anterior uveitis. 8 The value of diagnosing and screening for tick-borne diseases in dogs has gained increasing importance as tick distributions have expanded geographically, morbidity associated with acute or chronic infection and coinfections has been defined, and effective acaricide products have been developed. 3, 13, 15, 18, 22 Indirect immunofluorescent antibody (IFA) 745932V DIXXX10.1177/1040638717745932Characterization of in-clinic Anaplasma antibody assaysLiu et al.
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Department of Assay R&D, IDEXX Laboratories Inc., Westbrook, ME (Liu, Bewsey, O'Connor, Chandrashekar); Lakeland Veterinary Hospital, N. Baxter, MN (Eberts) 12,21 Speciation can be achieved using PCR methods using whole blood samples. 5, 12 In a 2014 study, a species-specific ELISA was reported. 18 The SNAP test (SNAP 4Dx Plus test, IDEXX Laboratories, Westbrook, ME) is a rapid in-house ELISA previously validated for concurrent detection of antibodies to A. phagocytophilum, A. platys, E. canis, Ehrlichia ewingii, B. burgdorferi, and heartworm antigen. 9, 13, 16, 21 The VetScan test (VetScan Canine Anaplasma Rapid test, Abaxis, Union City, CA) is commercially available for detection of Anaplasma antibodies but its performance has not been reported, to our knowledge. We compared the performance of these 2 tests for the detection of Anaplasma antibodies in naturally exposed dogs. For our study, only the Anaplasma portion of the SNAP test was assessed.
Study samples for A. phagocytophilum were collected from regional IDEXX Reference Laboratories and individual clinics located in northeast and upper midwest United States. Samples were originally submitted to the reference laboratories for A. phagocytophilum IFA testing unrelated to our study. Sera or plasma were collected after requested testing was completed by the reference laboratory; IFA results were used as the reference for these samples (IFA titer cutoff ≥ 1:50). Samples (n = 236) were obtained, with a majority from IDEXX Reference Laboratories and 83 from 2 clinics. One-half of the samples (n = 118) were IFA reactive with a wide range of IFA titers (Fig. 1) .
To identify A. platys samples, archived sera originally collected from dogs living in the southwestern United Sates (Hopi Reservation, AZ) were screened at IDEXX Laboratories (Westbrook, ME) using an A. platys-specific ELISA. 6, 18 The peptide reagent used in this ELISA was distinctly different from the one used in the SNAP test. One hundred seventy-nine samples were identified: 59 positive and 120 negative.
Samples were randomized and blind-labeled before testing with the SNAP and VetScan tests. There were no additional freeze-thaw cycle or sample handling differences in testing events between the 2 tests. Testing and visual interpretation of results were performed following the manufacturers' instructions supplied with each test kit. Each test result was interpreted independently by 3 laboratory technicians without knowledge of the IFA or ELISA results. Tests were designated positive or negative based on a consensus of 2 or 3 technicians.
Statistical analysis was performed (SAS v.9.4, SAS Institute, Cary, NC). Sensitivity and specificity for rapid tests were determined using the IFA or species-specific ELISA results as the reference method. Statistical significance was determined by McNemar exact tests (α = 0.05). To adjust for multiple comparisons, we used the step-down Holm-Bonferroni method applied to the exact McNemar p values, which allowed control for the family-wise error rate in the strong sense without independence assumption.
Using A. phagocytophilum IFA as the reference method, the SNAP test demonstrated significantly higher sensitivity (84.7% for SNAP and 39.0% for VetScan, p < 0.001) and specificity (95.8% for SNAP and 85.6% for VetScan, p = 0.0118; Table 1 ). Compared to the A. platys-specific ELISA, sensitivity was 83.1% and specificity was 99.2% for the SNAP test, and 57.6% and 82.5% for the VetScan test, respectively. These differences between SNAP and VetScan were also statistically significant (p = 0.0026 for sensitivity and p < 0.001 for specificity). Test sensitivity was plotted for samples within different titer level groups for all IFA seropositive samples (Fig. 1) . Among the 118 A. phagocytophilum IFA seropositive samples, there were 72 VetScan-negative results and 18 SNAPnegative results. VetScan was false negative for more than half of the samples in every titer range, including the highest titer range (≥1:3,200). SNAP sensitivity was significantly higher for the following titer groups: 1:200-1:400 (p < 0.0001), 1:800-1:1,600 (p < 0.0001), and ≥3,200 (p = 0.0156).
To further compare performance of the 2 test kits in a clinic setting, a study was conducted in a veterinary hospital in Minnesota, an area endemic for A. phagocytophilum. Dogs were tested at the sole discretion of the attending veterinarians with fresh whole blood samples. The SNAP and VetScan tests were run side-by-side for comparison according to the manufacturers' instructions. Certified veterinary technicians performed tests and recorded results. Different kit lots were used in the clinic study than those used in the study described above for both SNAP and VetScan tests. A total of 154 dogs were tested in a period of over 4 Discrepant results between IFA and rapid tests are more commonly found within low titer samples, which may be related to enhanced IFA sensitivity or, potentially, a lack of IFA specificity associated with cross-reactivity to other species of bacteria. 17 Reduced sensitivity found in the VetScan test for high titer samples may indicate an issue in assay design or failure of the test to detect antibodies to all A. phagocytophilum variants, which could be a result of the antigen used in the test. 12, 14 
